As ART bears senolytic activity, is well tolerated, and is already widely used in malaria therapy, it can be considered a repurposed drug useful not only in combination with temozolomide but also after a genotoxic therapy interval for clearing therapy-induced senescent cells in IDH1-mutated and non-mutated gliomas. The gene discussed is IDH1; the disease is central nervous system cancer.